Opthea Ltd Cash Flow Conversion Efficiency
Opthea Ltd cash flow conversion efficiency. Based on the latest financial reports, Opthea Ltd (OPT) has a cash flow conversion efficiency ratio of 0.460x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-92.00 Million ≈ $-65.10 Million USD) by net assets (AU$-200.16 Million ≈ $-141.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Opthea Ltd (1991–2025)
Cash flow conversion efficiency of Opthea Ltd from 1991 to 2025. This chart illustrates how Opthea Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Opthea Ltd stock quote for real-time trading data and today's change.
Opthea Ltd Cash Flow Conversion Ratio Explained
Opthea Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Opthea Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opthea Ltd ranked by their cash flow conversion efficiency. Also see market value of Opthea Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VL E-Governance & IT Solutions Limited
NSE:VLEGOV
|
N/A |
|
Chesnara
LSE:CSN
|
1.212x |
|
Telcon Inc
KQ:200230
|
-0.016x |
|
Pacific Horizon Investment Trust
LSE:PHI
|
0.001x |
|
Mint Incorporation Limited Class A Ordinary Shares
NASDAQ:MIMI
|
N/A |
|
BIGG Digital Assets Inc
F:7111
|
-0.096x |
|
PT Cilacap Samudera Fishing Industry Tbk
JK:ASHA
|
-0.014x |
|
AHB Holdings Bhd
KLSE:7315
|
-0.046x |
Annual Cash Flow Conversion Efficiency for Opthea Ltd (1991–2025)
The table below shows the annual cash flow conversion efficiency of Opthea Ltd from 1991 to 2025. Review OPT cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-201.07 Million ≈ $-142.27 Million |
AU$-158.64 Million ≈ $-112.25 Million |
0.789x | -62.85% |
| 2024-06-30 | AU$-75.81 Million ≈ $-53.64 Million |
AU$-161.02 Million ≈ $-113.93 Million |
2.124x | -89.58% |
| 2023-06-30 | AU$-8.79 Million ≈ $-6.22 Million |
AU$-179.30 Million ≈ $-126.87 Million |
20.391x | +1546.31% |
| 2022-06-30 | AU$69.77 Million ≈ $49.37 Million |
AU$-98.37 Million ≈ $-69.60 Million |
-1.410x | -316.10% |
| 2021-06-30 | AU$180.20 Million ≈ $127.50 Million |
AU$-61.06 Million ≈ $-43.20 Million |
-0.339x | -166.36% |
| 2020-06-30 | AU$64.81 Million ≈ $45.86 Million |
AU$-8.24 Million ≈ $-5.83 Million |
-0.127x | +83.63% |
| 2019-06-30 | AU$31.12 Million ≈ $22.02 Million |
AU$-24.19 Million ≈ $-17.11 Million |
-0.777x | -48.80% |
| 2018-06-30 | AU$38.17 Million ≈ $27.01 Million |
AU$-19.94 Million ≈ $-14.11 Million |
-0.522x | -370.79% |
| 2017-06-30 | AU$54.49 Million ≈ $38.56 Million |
AU$-6.05 Million ≈ $-4.28 Million |
-0.111x | +54.86% |
| 2016-06-30 | AU$14.98 Million ≈ $10.60 Million |
AU$-3.68 Million ≈ $-2.60 Million |
-0.246x | +18.54% |
| 2015-06-30 | AU$16.66 Million ≈ $11.79 Million |
AU$-5.03 Million ≈ $-3.56 Million |
-0.302x | +28.69% |
| 2014-06-30 | AU$9.87 Million ≈ $6.98 Million |
AU$-4.17 Million ≈ $-2.95 Million |
-0.423x | +1.23% |
| 2013-06-30 | AU$13.10 Million ≈ $9.27 Million |
AU$-5.61 Million ≈ $-3.97 Million |
-0.428x | -23.41% |
| 2012-06-30 | AU$20.67 Million ≈ $14.62 Million |
AU$-7.17 Million ≈ $-5.08 Million |
-0.347x | +14.02% |
| 2011-06-30 | AU$23.32 Million ≈ $16.50 Million |
AU$-9.42 Million ≈ $-6.66 Million |
-0.404x | -44.72% |
| 2010-06-30 | AU$27.04 Million ≈ $19.13 Million |
AU$-7.54 Million ≈ $-5.34 Million |
-0.279x | -32.46% |
| 2009-06-30 | AU$31.29 Million ≈ $22.14 Million |
AU$-6.59 Million ≈ $-4.66 Million |
-0.211x | -475.98% |
| 2008-06-30 | AU$49.18 Million ≈ $34.80 Million |
AU$-1.80 Million ≈ $-1.27 Million |
-0.037x | -105.73% |
| 2007-06-30 | AU$51.71 Million ≈ $36.59 Million |
AU$32.97 Million ≈ $23.33 Million |
0.638x | +1028.75% |
| 2006-06-30 | AU$42.07 Million ≈ $29.77 Million |
AU$-2.89 Million ≈ $-2.04 Million |
-0.069x | -20.11% |
| 2005-06-30 | AU$28.63 Million ≈ $20.26 Million |
AU$-1.64 Million ≈ $-1.16 Million |
-0.057x | +2.50% |
| 2004-06-30 | AU$29.15 Million ≈ $20.63 Million |
AU$-1.71 Million ≈ $-1.21 Million |
-0.059x | -31.10% |
| 2002-06-30 | AU$23.28 Million ≈ $16.47 Million |
AU$-1.04 Million ≈ $-736.53K |
-0.045x | -7.66% |
| 2001-06-30 | AU$24.20 Million ≈ $17.12 Million |
AU$-1.01 Million ≈ $-711.19K |
-0.042x | +87.30% |
| 1997-06-30 | AU$5.32 Million ≈ $3.77 Million |
AU$-1.74 Million ≈ $-1.23 Million |
-0.327x | -3.21% |
| 1996-06-30 | AU$3.83 Million ≈ $2.71 Million |
AU$-1.22 Million ≈ $-859.69K |
-0.317x | +2.21% |
| 1995-06-30 | AU$2.07 Million ≈ $1.47 Million |
AU$-672.00K ≈ $-475.48K |
-0.324x | -44.64% |
| 1994-06-30 | AU$2.09 Million ≈ $1.48 Million |
AU$-469.00K ≈ $-331.85K |
-0.224x | -3.14% |
| 1993-06-30 | AU$1.62 Million ≈ $1.14 Million |
AU$-351.00K ≈ $-248.35K |
-0.217x | -32.60% |
| 1992-06-30 | AU$1.63 Million ≈ $1.15 Million |
AU$-267.00K ≈ $-188.92K |
-0.164x | -7.51% |
| 1991-06-30 | AU$1.29 Million ≈ $914.88K |
AU$-197.00K ≈ $-139.39K |
-0.152x | -- |
About Opthea Ltd
Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME).… Read more